If you’ve been diagnosed with breast cancer, you’ve had to make some tough decisions about what treatment to pursue. But perhaps the most important decision you’ve had to make was what to do to minimise the likelihood of recurrence after the tumor was gone.
Each year, more than 44,000 women are diagnosed with breast cancer in the UK, and billions of pounds are spent on cancer treatment. It’s big business, and competition among drug manufacturers to prevent the disease’s recurrence is fierce.
The drugs most often prescribed for breast cancer patients are tamoxifen, raloxifene, Arimidex®, and the newest and most controversial kid on the block, Herceptin®. But how effective are they? What are their side effects, and how do they compare with treatment approaches that focus on diet, nutritional supplements, and lifestyle changes? Let’s take a look at them.
Answers to these questions & more are available to 100% Health Club Members
